Vericel to Present at 2016 Cell & Gene Meeting on the Mesa
September 26 2016 - 8:00AM
Vericel Corporation (Nasdaq:VCEL), a leading developer of
autologous cellular therapies for the treatment of severe diseases
and conditions, today announced that Nick Colangelo, president and
CEO, will present at the annual Cell & Gene Meeting on the Mesa
at the Estancia La Jolla Hotel & Spa in La Jolla, CA on
Wednesday, October 5, 2016 at 5:45pm Pacific time.
Organized by ARM and the Sanford Consortium for Regenerative
Medicine, the Cell & Gene Meeting on the Mesa is a three-day
conference organized specifically for the cell and gene therapy and
regenerative medicine sector.
The presentation will be webcast live at:
http://www.meetingonthemesa.com/webcast/ and will also be published
on ARM’s website shortly after the event.
About Vericel CorporationVericel develops,
manufactures, and markets autologous expanded cell therapies for
the treatment of patients with serious diseases and
conditions. The company markets two cell therapy products in
the United States. Carticel® (autologous cultured
chondrocytes) is an autologous chondrocyte implant for the
treatment of cartilage defects in the knee in patients who have had
an inadequate response to a prior arthroscopic or other surgical
repair procedure. Epicel® (cultured epidermal autografts) is
a permanent skin replacement for the treatment of patients with
deep dermal or full thickness burns greater than or equal to 30% of
total body surface area. Vericel is also developing two
additional cell products. MACI® is a third generation
autologous chondrocyte implant intended to treat cartilage defects
in the knee. Ixmyelocel‑T is an autologous multicellular
therapy intended to treat advanced heart failure due to ischemic
dilated cardiomyopathy (DCM). For more information, please
visit the company's website at www.vcel.com.
Epicel®, Carticel® and MACI® are registered trademarks of
Vericel Corporation. ©2016 Vericel Corporation. All
rights reserved.
CONTACT:
Chad Rubin
The Trout Group
crubin@troutgroup.com
(646) 378-2947
or
Lee Stern
The Trout Group
lstern@troutgroup.com
(646) 378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024